Bennicas & Associates, Inc. / LLY
Bennicas & Associates, Inc.’s Eli Lilly & Co Position
Does Bennicas & Associates, Inc. own Eli Lilly & Co (LLY)? Yes — 7.3K shares worth $3M (+1.54% of its 13F portfolio) as of Q1 2023.
Position Value
$3M
Q1 2023
Shares
7.3K
% of Portfolio
+1.54%
Quarters Held
18
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2023 | 7.3K | $3M | +1.54% |
| Q4 2022 | 7.3K | $3M | +1.54% |
| Q3 2022 | 7.9K | $3M | +1.62% |
| Q2 2022 | 7.9K | $3M | +1.50% |
| Q1 2022 | 8.2K | $2M | +1.18% |
| Q4 2021 | 9.9K | $3M | +1.42% |
| Q3 2021 | 9.9K | $2M | +1.29% |
| Q2 2021 | 10.6K | $2M | +1.34% |
| Q1 2021 | 10.6K | $2M | +1.14% |
| Q4 2020 | 11.1K | $2M | +1.09% |
| Q3 2020 | 11.0K | $2M | +1.02% |
| Q2 2020 | 11.1K | $2M | +1.37% |
| Q1 2020 | 11.7K | $2M | +1.44% |
| Q4 2019 | 13.3K | $2M | +1.27% |
| Q3 2019 | 14.4K | $2M | +1.25% |
| Q2 2019 | 14.3K | $2M | +1.33% |
| Q1 2019 | 14.6K | $2M | +1.67% |
| Q4 2018 | 15.2K | $2M | +1.62% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bennicas & Associates, Inc.’s full portfolio or all institutional holders of LLY.